BLISSGVS — Bliss GVS Pharma Income Statement
0.000.00%
Last trade - 00:00
- IN₹12.84bn
- IN₹12.46bn
- IN₹7.52bn
- 82
- 34
- 84
- 80
2019 March 31st | C2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8,982 | 6,893 | 5,772 | 7,475 | 7,516 |
Cost of Revenue | |||||
Gross Profit | 2,389 | 2,435 | 2,402 | 3,482 | 3,431 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7,472 | 5,920 | 4,878 | 7,200 | 6,529 |
Operating Profit | 1,511 | 973 | 894 | 274 | 986 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,819 | 1,290 | 1,041 | 542 | 1,061 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,267 | 953 | 740 | 231 | 767 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1,237 | 973 | 685 | 150 | 709 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,237 | 973 | 685 | 150 | 709 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 12.1 | 10.4 | 6.5 | 4.42 | 6.69 |
Dividends per Share |